2012, Volume 14, Issue 8
Strategic Study of CAE >> 2012, Volume 14, Issue 8
The boron neutorn capture therapy (BNCT) status to go into the new era
China Zhongyuan Engineering Corporation, China National Nuclear Corporation, Beijing 100191, China
Next Previous
Abstract
The paper briefly interprets the obvious progress of the boron neutorn capture therapy (BNCT) in the new era. It includes the BNCT clinical positioning, the tumour recurrence exploring, the boron concentration quantifed detecting, the targeting boron compound composing and the in hospitor neutron source irradintors setting up. The enlargement of these bottle necks in BNCT developing might be the preview of personalizing and routine BNCT.
Keywords
neutron capture therapy ; clinical trial ; tumour recurrence ; boron concentration detect ; targeting boron compound ; in hospital neutron irradiator
Figures
图1
References
[ 1 ] Aris Z. BNCT:a new option against cancer(president´s address) [C]//Proceeding of 13th ICNCT. Florence, Italy,2008:5-6.
[ 2 ] Barth R F. What is the future for BNCT[C]//Proceeding of 13th ICNCT. Florence, Italy,2008:133-137.
[ 3 ] KentJ R. Collective analysis of clinical outcomes: globally advancing BNCT[C]//Proceeding of 13th ICNCT. Florence, Italy,2008:132.
[ 4 ] Hiroshi F, Jun-i H. BNCT for malignant melanoma and head and neck cancer: from developmental stage to clinical trial[C]//Proceeding of 13th ICNCT. Florence, Italy,2008:68-70.
[ 5 ] Yang W, Barth B F, Wu G, et al. Molecular targeting of the epidermal growth factor receptor for BNCT of brain gliomas[R].Ohio, USA: The Ohio State University,2011.
[ 6 ] Carlsson J, Erika B K, Jacek C, et al. Ligand liposomes and BNCT[J]. Journal of Neuro-Oncology,2003,62(1/2):47-59. link1
[ 7 ] luligi M, Anna FC, Teresa C, et al. Boron carriers for BNCT: state of the art new perspectives deriving from nanotechnology[C]//Proceeding of 13th ICNCT. Florence, Italy,2008:233.
京公网安备 11010502051620号
